ilo Research

ilo Research is a biotechnology company based in Oxford, UK, specializing in the development of circular RNA (circRNA) therapeutics. Spun out of the University of Cambridge, the company leverages a proprietary platform to design and engineer programmable circRNA molecules with enhanced stability and translation efficiency compared to traditional linear mRNA. Their technology aims to address the limitations of current RNA therapies by enabling long-lasting protein expression, potentially transforming the treatment landscape for a variety of genetic and chronic diseases. Backed by investors such as Oxford Science Enterprises, ilo Research is actively advancing its internal pipeline and exploring strategic collaborations to harness the potential of circular RNA biology.